Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
26.62
+0.63 (2.42%)
At close: Jun 9, 2025, 4:00 PM
26.60
-0.02 (-0.08%)
After-hours: Jun 9, 2025, 7:45 PM EDT
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Amphastar Pharmaceuticals stock ranges from a low of $30 to a high of $55. The average analyst price target of $38 forecasts a 42.75% increase in the stock price over the next year.
Price Target: $38.00 (+42.75%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Amphastar Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 2 | 1 | 1 | 2 | 2 |
| Hold | 1 | 2 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 3 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy → Hold Downgrades $45 → $30 | Buy → Hold | Downgrades | $45 → $30 | +12.70% | May 12, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +31.48% | May 8, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 10, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $36 → $32 | Hold | Maintains | $36 → $32 | +20.21% | Mar 21, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $66 → $36 | Buy → Hold | Downgrades | $66 → $36 | +35.24% | Feb 4, 2025 |
Financial Forecast
Revenue This Year
736.85M
from 731.97M
Increased by 0.67%
Revenue Next Year
775.04M
from 736.85M
Increased by 5.18%
EPS This Year
3.22
from 3.06
Increased by 5.11%
EPS Next Year
3.58
from 3.22
Increased by 11.36%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 767.6M | 843.2M | 882.3M | ||
| Avg | 736.9M | 775.0M | 797.9M | ||
| Low | 701.7M | 711.5M | 716.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.9% | 14.4% | 13.8% | ||
| Avg | 0.7% | 5.2% | 3.0% | ||
| Low | -4.1% | -3.4% | -7.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.60 | 3.83 | 4.04 | ||
| Avg | 3.22 | 3.58 | 3.78 | ||
| Low | 2.95 | 3.08 | 3.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.7% | 19.1% | 12.9% | ||
| Avg | 5.1% | 11.4% | 5.6% | ||
| Low | -3.6% | -4.3% | -8.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.